Correlation Between Eli Lilly and Oric Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Oric Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Oric Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Oric Pharmaceuticals, you can compare the effects of market volatilities on Eli Lilly and Oric Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Oric Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Oric Pharmaceuticals.
Diversification Opportunities for Eli Lilly and Oric Pharmaceuticals
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eli and Oric is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Oric Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oric Pharmaceuticals and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Oric Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oric Pharmaceuticals has no effect on the direction of Eli Lilly i.e., Eli Lilly and Oric Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eli Lilly and Oric Pharmaceuticals
Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.41 times more return on investment than Oric Pharmaceuticals. However, Eli Lilly and is 2.43 times less risky than Oric Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Oric Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest 35,722 in Eli Lilly and on September 25, 2024 and sell it today you would earn a total of 43,831 from holding Eli Lilly and or generate 122.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Eli Lilly and vs. Oric Pharmaceuticals
Performance |
| Timeline |
| Eli Lilly |
| Oric Pharmaceuticals |
Eli Lilly and Oric Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eli Lilly and Oric Pharmaceuticals
The main advantage of trading using opposite Eli Lilly and Oric Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Oric Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oric Pharmaceuticals will offset losses from the drop in Oric Pharmaceuticals' long position.| Eli Lilly vs. Johnson Johnson | Eli Lilly vs. Bristol Myers Squibb | Eli Lilly vs. AbbVie Inc | Eli Lilly vs. Pfizer Inc |
| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |